mbiomics GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
mbiomics GmbH - overview
Established
2020
Location
Munich, -, Germany
Primary Industry
Biotechnology
About
Founded in 2020 and based in Munich, Germany, Mbiomics GmbH operates as a biotechnology company that focuses on researching therapeutic approaches using the microbiome. Laura Figulla (CEO), Markus Rinecker (CMO/CFO), Johannes B. Woehrstein (CTO), and Heinrich Grabmayr are the co-founders of the company. In March 2023, Mbiomics GmbH raised EUR 13 million in Series A funding from MIG Verwaltungs AG, including Bayern Kapital and High-Tech Gründerfonds.
The company offers a variety of products, such as Mbiomics Gold, the gold standard for microbiome analysis, which allows for comparable gut microbiome profiling; Mbiomics Monitor, which enables users to monitor microbiome modulation with sampling frequency; and the Mbiomics Stratos Platform, which enables microbiome profiling by combining biomarker panels and turnaround times. The firm’s partners include the University of Zurich and TUM. The organization plans to use the March 2023 funding to increase the number of its employees as it plans to expand its business reach nationwide.
Current Investors
High-Tech Gruenderfonds, MIG Capital, Bayern Kapital
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals
Website
www.mbiomics.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.